Hyperpituitarism: Clinical Trials

5 trials for Hyperpituitarism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Hyperpituitarism: new trials by email Literature Review of Hyperpituitarism trials Research Report on Hyperpituitarism

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pasireotide LAR and Pegvisomant Study in Acromegaly
Pasireotide LAR 60 mg, Pegvisomant - Acromegaly
Phase 4UnknownErasmus Medical Center602015-08-012016-08-03
Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
Sandostatin (Octreotide Acetate) - Acromegaly
Phase 4UnknownAsan Medical Center12014-03-012015-04-28
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
Aripiprazole, risperidone or paliperidone - Sexual Dysfunction, Hyperprolactinemia
Phase 4UnknownSi Tianmei1202013-02-012013-03-14
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Abilify (aripiprazole) - Hyperprolactinemia, Weight Gain
Phase 4UnknownGenovate Biotechnology Co., Ltd.,2007-10-012007-10-10
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
pegvisomant - Acromegaly, Heart Failure
Phase 4UnknownUniversity of Wuerzburg42006-06-012010-09-24

Narrower conditions

Acromegaly (3)  ·  Hyperprolactinemia (2)  ·  Cardiomegaly (1)  ·  Dyslipidemias (1)  ·  Heart Failure (1)  ·  Hypertrophy (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Schizophrenia (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Weight Gain (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Endocrine System Diseases (5)  ·  Hypothalamic Diseases (5)  ·  Nervous System Diseases (5)  ·  Pituitary Diseases (5)  ·  Bone Diseases (3)  ·  Bone Diseases, Endocrine (3)  ·  Musculoskeletal Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Cardiovascular Diseases (1)  ·  Genital Diseases (1)

Interventions

Aripiprazole (2)  ·  pegvisomant (2)  ·  Octreotide (1)  ·  Paliperidone Palmitate (1)  ·  Risperidone (1)  ·  pasireotide (1)

Sponsors

Asan Medical Center (1)  ·  Erasmus Medical Center (1)  ·  Genovate Biotechnology Co., Ltd., (1)  ·  Si Tianmei (1)  ·  University of Wuerzburg (1)

Countries

China (1)  ·  Germany (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Bruno Allolio, MD (1)  ·  Chen Chih-Ken, PhD (1)  ·  Sebastian Neggers, MD PhD (1)

Results publications

PMID 20732372, PMID 29155991

NIH funding

2014 (1)